SCHEMBL980600

SCHEMBL980600

CCOc1ccc(-c2cccc(NC(=O)c3cc4cccc(OC)c4oc3=O)c2)cc1C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.58
GLA P06280 1/20 0.58
TP53 P04637 2/20 0.58
MAPT P10636 1/20 0.58
CASP3 P42574 1/20 0.57
PPARG P37231 1/20 0.57
NCOA2 Q15596 1/20 0.57
NCOA1 Q15788 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
NCOA3 Q9Y6Q9 1/20 0.57
RAB9A P51151 1/20 0.55
HSD17B10 Q99714 1/20 0.55
RXFP1 Q9HBX9 2/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
KDM4E B2RXH2 1/20 0.52
ADORA3 P0DMS8 1/20 0.51
MAOA P21397 1/20 0.51
MAOB P27338 1/20 0.51
KCNK3 O14649 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL980544 0.91 ALDH1A1 (0.55) ALDH1A1GLATP53MAPTCASP3
SCHEMBL978098 0.90 ALDH1A1 (0.55) ALDH1A1GLATP53MAPTCASP3
SCHEMBL980540 0.89 MAPT (0.59) ALDH1A1GLATP53MAPTCASP3
SCHEMBL983054 0.83 CASP3 (0.63) ALDH1A1TP53MAPTCASP3RAB9A
SCHEMBL981815 0.82 CASP3 (0.62) ALDH1A1TP53MAPTCASP3RAB9A
SCHEMBL981013 0.82 CASP3 (0.61) ALDH1A1TP53MAPTCASP3RAB9A
SCHEMBL982902 0.82 CASP3 (0.61) ALDH1A1GLATP53MAPTCASP3
SCHEMBL978574 0.82 ALDH1A1 (0.58) ALDH1A1GLATP53MAPTCASP3
SCHEMBL980237 0.81 CASP3 (0.63) ALDH1A1TP53MAPTCASP3RAB9A
SCHEMBL980492 0.81 CASP3 (0.65) ALDH1A1TP53MAPTCASP3RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110021522-A1 ACTIVATORS OF EXECUTIONER PROCASPASES 3, 6 AND 7 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021522-A1 ACTIVATORS OF EXECUTIONER PROCASPASES 3, 6 AND 7 CASP7, CASP3, CASP6 ALDH1A1 2806/4885GLA 467/4885TP53 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.